Tel Aviv, Israel

Carmel Pundak-Mintz

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tel Aviv University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carmel Pundak-Mintz. Retrieved from https://idiyas.com/inventor/carmel-pundak-mintz-exustlwi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carmel Pundak-Mintz: Innovator in Gene Targeting Technology

Introduction

Carmel Pundak-Mintz is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of genetic engineering, particularly in the area of gene targeting technology. His work has implications for immunotherapy and other medical applications.

Latest Patents

Carmel Pundak-Mintz holds a patent for "Recombination activating gene (RAG) induced V(D)J gene targeting." This invention relates to methods for the targeted insertion of nucleic acid sequences into a target genomic locus of a mammalian cell. The methods utilize nucleic acid cassettes that include recognition signal sequences for the insertion process, which is mediated by RAG-catalyzed recombination. The invention also encompasses cassettes, vectors, vehicles, and cells that incorporate these cassettes, along with their compositions and uses in immunotherapy. He has 1 patent to his name.

Career Highlights

Carmel Pundak-Mintz is affiliated with Tel Aviv University, where he conducts research and develops innovative technologies. His work has positioned him as a key figure in the advancement of genetic engineering techniques.

Collaborations

Carmel has collaborated with notable colleagues, including Daniel Nataf and Miriam Fried. Their combined expertise contributes to the success of their research initiatives.

Conclusion

Carmel Pundak-Mintz is a pioneering inventor whose work in gene targeting technology is shaping the future of immunotherapy. His contributions are vital to advancements in genetic engineering and medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…